New hope for sleepy kids: testing simpler narcolepsy treatment
NCT ID NCT06809803
Summary
This study is testing whether children with narcolepsy type 1 prefer a new extended-release version of sodium oxybate that's taken just once per night, compared to standard treatments that require multiple doses. Researchers will enroll 36 children to compare the safety, convenience, and effectiveness of the two approaches. The study aims to see if the once-nightly option better controls symptoms like daytime sleepiness and sudden muscle weakness (cataplexy).
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY TYPE 1 (NT 1) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
RECRUITINGRedwood City, California, 94063, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.